drugset / Trial / NCT02654093

A Drug-drug Interaction Study of DP-R213

NCT02654093

Phase 1 Completed 24 enrolled Alvogen Korea
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to learn about the effect of raloxifene on how the body absorbs and processes cholecalciferol and how cholecalciferol affects raloxifene when they are taken together.

Timeline

Start
2016-01
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified Oral
Subject Raloxifene Other / unclassified Oral

Indications

No indication recorded.